An FDA advisory panel voted against recommending approval for Intrinsic Therapeutic's Barricaid prosthesis designed for partial annulus replacement in patients with herniated discs.
News & Features
Smith & Nephew's MolecuLight iX is designed to detect bacteria in hard-to-heal wounds using only light.
The five-state settlement closes litigation over Medtronic's controversial Infuse bone graft device.
Virtual Incision raised $18 million in funding to support an FDA 510(k) submission for its miniaturized robotically assisted surgical device. Here's what sets this robotic device apart in an increasingly popular field.
Industry trade groups are applauding a House proposal to suspend the U.S. medical device tax for another five years, but the measure falls short of offering the industry a long-term solution.
NuVasive has agreed to acquire SafePassage, a provider of intraoperative neurophysiological monitoring services, for an undisclosed amount.
Unlike traditional DBS systems that are built from pacemaker technology, this device is modeled from cochlear implant technology and the precise stimulation of auditory nerves it uses to replicate hearing.
A recent uptick in tuck-in acquisitions prompted a closer look at M&A trends across the industry. Here are five insights we uncovered.
Medtronic has bought endoscopic diagnostic player Crospon, the target company's CEO announced via LinkedIn and Twitter. Official details have not been released, but some media reports put the deal value at around $45 million.
The U.S. market for dental Bone graft substitutes and other biomaterials is growing in response to the growth of the dental implants market.